Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease

Asa Johansson1, Joanne E Curran, Matthew P Johnson

  • 1Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. asa.johansson@ucr.uu.se

Insights

Downregulation of the ACOX2 gene is linked to preeclampsia (PE) and later cardiovascular disease (CVD). This gene

Area of Science:

  • Genetics and Molecular Biology
  • Obstetrics and Gynecology
  • Cardiovascular Medicine

Background:

  • Preeclampsia (PE) is a pregnancy complication strongly associated with future cardiovascular disease (CVD).
  • Shared genetic factors between PE and CVD are not well understood.
  • Lipid traits are potential common risk factors for both conditions.

Purpose of the Study:

  • To investigate lipid traits as shared risk factors for PE and CVD.
  • To identify genes involved in the pathogenesis of PE and their potential link to CVD.
  • To explore the role of ACOX2 gene in the development of PE and CVD.

Main Methods:

  • Whole genome transcriptional profiling of Norwegian decidua basalis tissues (N=95) from PE and normal pregnancies.
  • Analysis of blood lymphocytes (N=1240) from the San Antonio Family Heart Study (SAFHS).
  • Identification of differentially expressed genes and association analysis with lipid traits and SNPs.

Main Results:

  • One gene, ACOX2 (acyl-coenzyme A oxidase 2, branched chain), was found downregulated in PE.
  • ACOX2 transcription inversely correlated with triglyceride levels in SAFHS (P = 5.6 × 10⁻⁷).
  • Single nucleotide polymorphisms (SNPs) in ACOX2 associated with gene transcription levels and triglyceride levels.

Conclusions:

  • Downregulation of ACOX2 is a potential shared genetic risk factor for PE and CVD.
  • ACOX2's role in bile acid production links it to oxidative stress and triglyceride regulation, key factors in both PE and CVD.
  • Further research into ACOX2 may reveal therapeutic targets for preventing PE and CVD.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Punnett Squares01:00

Punnett Squares

Overview